Co-Diagnostics Inc
(CODX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,859 | 23,099 | 14,917 | 10,240 | 13,831 |
| Marketable Securities | 31,021 | 26,864 | 43,632 | 53,189 | 55,307 |
| Receivables | 552 | 435 | 331 | 2,053 | 2,537 |
| Inventories | 1,464 | 1,550 | 1,665 | 4,520 | 4,691 |
| Other current assets | 0 | 0 | 0 | 19 | 38 |
| TOTAL | $48,219 | $53,699 | $62,141 | $71,311 | $77,385 |
| Non-Current Assets | |||||
| PPE Net | 3,055 | 3,183 | 3,036 | 2,808 | 2,795 |
| Investments And Advances | 628 | 702 | 773 | 779 | 825 |
| Intangibles | 26,252 | 26,328 | 26,404 | 26,479 | 26,555 |
| Other Non-Current Assets | 2,548 | 2,759 | 2,967 | 7,305 | 5,241 |
| TOTAL | $32,482 | $32,972 | $33,180 | $37,371 | $35,416 |
| Total Assets | $80,702 | $86,671 | $95,321 | $108,682 | $112,801 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,864 | 2,028 | 1,482 | 1,416 | 1,712 |
| Accrued Expenses | 1,505 | 1,325 | 2,173 | 1,827 | 1,629 |
| Other current liabilities | 838 | 751 | 892 | 711 | 744 |
| TOTAL | $5,305 | $5,270 | $5,748 | $5,098 | $5,116 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 221 | 307 | 362 | 350 | 258 |
| Other Non-Current Liabilities | 2,299 | 2,370 | 2,900 | 2,735 | 3,049 |
| TOTAL | $2,998 | $3,049 | $3,560 | $4,095 | $4,253 |
| Total Liabilities | $8,304 | $8,319 | $9,307 | $9,192 | $9,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,063 | 1,042 | 1,041 | 1,018 | 1,025 |
| Common Shares | 37 | 36 | 36 | 35 | 35 |
| Retained earnings | -12,313 | -4,714 | 4,598 | 19,275 | 25,257 |
| Other shareholders' equity | 795 | 651 | 571 | 197 | 329 |
| TOTAL | $72,398 | $78,353 | $86,014 | $99,490 | $103,432 |
| Total Liabilities And Equity | $80,702 | $86,671 | $95,321 | $108,682 | $112,801 |